次谐波辅助压力估计用于监测肿瘤间质液压力:乳腺癌异种移植瘤中的校准与紫杉醇治疗评估
研究用次谐波辅助压力估计(SHAPE)无创估计乳腺癌异种移植大鼠的肿瘤间质液压力(IFP),并与有创压力监测仪比较;校准组建立IFP与SHAPE的逆线性关系(r=-0.69,p=0.01),治疗组测得与估计IFP相关r=0.74(p<0.05,平均误差6.24 mmHg);紫杉醇治疗前后两种方法均未见显著差异(p≥0.15)。
要点
- 校准组肿瘤IFP与SHAPE呈逆线性关系(y=-1.06x+28.27,r=-0.69,p=0.01)。
- 治疗组有创测得与SHAPE估计IFP相关r=0.74(p<0.05),平均误差6.24 mmHg。
- 紫杉醇治疗前后两种方法均未见显著差异(p≥0.15)。
核心结论
- SHAPE可用于无创估计乳腺癌异种移植瘤的IFP,治疗组中与有创压力监测仪读数相关r=0.74(p<0.05),平均误差6.24 mmHg;紫杉醇治疗前后两种方法均未见显著差异(p≥0.15)。
研究设计与样本
- 动物实验研究,89只大鼠注射5×10^6个乳腺癌细胞(MDA-MB-231),校准组25只、治疗组64只;39只成功采集射频信号,使用Sonix RP扫描仪(BK Ultrasound,Richmond,BC,Canada)及L9-4线阵探头(发射/接收:8/4 MHz),注射Definity(Lantheus Medical Imaging,North Billerica,MA,USA;180 μL/kg)后采集,并与有创压力监测仪(Stryker,Berkshire,UK)读数比较。
诊断标准与关键数值
- 校准组建立肿瘤IFP与SHAPE的逆线性关系:y=-1.06x+28.27,r=-0.69,p=0.01。
- 治疗组应用该关系后,有创测得与SHAPE估计IFP之间r=0.74(p<0.05),平均误差6.24 mmHg。
临床应用与阅片要点
- 作者采用SHAPE无创估计乳腺癌异种移植瘤的IFP,并与有创压力监测仪读数比较。
- 紫杉醇(5 mg/kg,Mayne Pharma,Paramus,NJ,USA)治疗前后,两种方法均未观察到显著差异(p≥0.15)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Interstitial fluid pressure (IFP) in rats with breast cancer xenografts was non-invasively estimated using subharmonic-aided pressure estimation (SHAPE) versus an invasive pressure monitor. Moreover, monitoring of IFP changes after chemotherapy was assessed. Eighty-nine rats (calibration n = 25, treatment n = 64) were injected with 5 × 106 breast cancer cells (MDA-MB-231). Radiofrequency signals were acquired (39 rats successfully imaged) with a Sonix RP scanner (BK Ultrasound, Richmond, BC, Canada) using a linear array (L9-4, transmit/receive: 8/4 MHz) after administration of Definity (Lantheus Medical Imaging, North Billerica, MA, USA; 180 μL/kg) and compared with readings from an invasive pressure monitor (Stryker, Berkshire, UK). An inverse linear relationship was established between tumor IFP and SHAPE (y = -1.06x + 28.27, r = -0.69, p = 0.01) in the calibration group. Use of this relationship in the treatment group resulted in r = 0.74 (p < 0.05) between measured (pressure monitor) and SHAPE-estimated IFP (average error: 6.24 mmHg). No significant before/after differences were observed with respect to paclitaxel treatment (5 mg/kg, Mayne Pharma, Paramus, NJ, USA) with either method (p ≥ 0.15).
引用
- Halldorsdottir VG, Dave JK, Marshall A, et al. Subharmonic-Aided Pressure Estimation for Monitoring Interstitial Fluid Pressure in Tumors: Calibration and Treatment with Paclitaxel in Breast Cancer Xenografts. Ultrasound Med Biol. 2017. PMID: 28433436. doi:10.1016/j.ultrasmedbio.2017.02.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。